COVID-19 Federal Responses: Thursday, January 14, 2021

COVID-19 Federal Responses: Thursday, January 14, 2021
  • As of Feb. 13, more than 10 million people were vaccinated with at least one dose of COVID-19 vaccine.

  • Johnson & Johnson anticipates submitting to FDA for EUA for its COVID vaccine by March

White House and Federal Agencies

  • Tonight, President-elect Biden will unveil a $1.9 trillion COVID-19 relief plan that is largely based on previous Democratic proposals such as the HEROES Act.
  • Centers for Medicare and Medicaid Services (CMS) released an updated version of its CMS Pandemic Plan, which provides details of the agency’s pandemic response – actions the agency is taking to support the healthcare system and beneficiaries.
  • The Food and Drug Administration (FDA) provides updates for health care workers on  COVID-19via the Resources for Health Professionals page.

Centers for Disease Control and Prevention (CDC) Updates

Vaccine, Testing and Treatment

  • As of Wednesday, 29.3 million doses of the Moderna and Pfizer COVID-19 vaccines have been distributed. More than 10 million people have received at least the first dose of a COVID-19 vaccine as of that date.
  • Health and Human Services (HHS) will stop holding back  second doses of COVID-19 vaccines and will instead make all doses available for immediate distribution.
  • HHS announced the launch of a web-based locator for COVID-19 outpatient treatment sites for monoclonal antibody therapeutics. The system helps doctors and patients find locations for COVID-19 outpatient treatment. Use of monoclonal antibody treatments could help reduce need for hospitalization in high-risk patients.
  • Johnson & Johnson is preparing to publish preliminary safety and efficacy data on its single dose COVID-19 vaccine. The company anticipates submitting data to the FDA for an emergency use authorization in March.
  • Moderna’s CEO expressed worry that COVID-19 will be around forever. It is not yet known how long the current vaccines will provide protection from the disease. Moderna plans to test its vaccine again in a year.
  • Moderna is struggling to find enough participants for adolescent trials for its COVID-19 vaccine.
  • The World Health Organization (WHO) does not anticipate global herd immunity from COVID-19 until 2022.